Research Progress of Nanovaccine in Tumor Immunotherapy
Author:
Affiliation:

1)The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China;2)College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China

Clc Number:

Fund Project:

This work was supported by grants from The National Natural Science Foundation of China(32000997), Natural Science Foundation of Nanjing University of Chinese Medicine (NZY32000997), Natural Science Fund for Colleges and Universities in Jiangsu Province (20KJB350004), Advantage Discipline Project of Traditional Chinese Medicine (ZYX03KF038), Innovation and Entrepreneurship Training Program for College Students in Jiangsu Province(202010315035Z).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    In recent years, tumor immunotherapy has become a hot spot in the field of cancer treatment. Among them, nanovaccines combining tumor vaccines and nanotechnology provide new ideas for tumor immunotherapy. Nanovaccine can realize the co-loading of vaccine and adjuvant. The intelligent nanocarriers further realize the effective targeted delivery of antigen, promote the uptake and presentation of antigen, specifically activate antigen-specific immune response and effectively kill tumor cells. This article reviews the principles, advantages, types of nano materials, and clinical efficacy of nanovaccine to provide a more reliable reference for the design of nano-vaccine in the later stage.

    Reference
    Related
    Cited by
Get Citation

MAO Jia-Rong, QIAN Ying, SHI Guo-Ping, WANG Jing-Jing, CHEN Yu-Gen. Research Progress of Nanovaccine in Tumor Immunotherapy[J]. Progress in Biochemistry and Biophysics,2021,48(10):1130-1136

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 11,2021
  • Revised:March 06,2021
  • Accepted:April 01,2021
  • Online: November 26,2021
  • Published: October 20,2021